NCT04026737View on ClinicalTrials.gov

Cardiovascular Effects of CART Cell Therapy

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

November 16, 2022

Study Completion Date

November 16, 2022

Conditions
LeukemiaLymphomaCardiotoxicityRisk Factor, CardiovascularImmunotherapy
Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT04026737 - Cardiovascular Effects of CART Cell Therapy | Biotech Hunter | Biotech Hunter